site stats

Dyne therapeutics stock

WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 … WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases.

Dyne Therapeutics, Inc. (DYN) Latest Stock News & Headlines

WebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular … WebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. greek organizations crafts https://mellowfoam.com

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives …

WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a 50 day simple moving average of $12.59 and a 200 day simple moving average of $12.09. Dyne Therapeutics has a 52-week low of $4.30 … WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that … WebApr 11, 2024 · A high-level overview of Dyne Therapeutics, Inc. (DYN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … greek origin names for boys

Dyne Therapeutics Rings the Nasdaq Stock Market Closing Bell

Category:Dyne Therapeutics Company Profile: Stock Performance

Tags:Dyne therapeutics stock

Dyne therapeutics stock

Stock Information Dyne Therapeutics, Inc.

WebApr 11, 2024 · Dyne Therapeutics Trading Down 6.0 %. DYN stock opened at $8.82 on Tuesday. The firm has a 50 day moving average of $12.59 and a 200-day moving … WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of …

Dyne therapeutics stock

Did you know?

WebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. WebDyne Therapeutics General Information. Description. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

WebApr 6, 2024 · Dyne Therapeutics. stock was originally listed at a price of $23.90 in Sep 17, 2024. If you had invested in Dyne Therapeutics stock at $23.90, your return over the … WebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular diseases. Read the full story here.

WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 after opening rate of $9.34 while the lowest price it went was recorded $8.77 before closing at $9.38.Recently in News on March 23, 2024, Dyne Therapeutics Receives FDA … WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a ...

WebOct 4, 2024 · Dyne Therapeutics (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, visits ...

WebApr 11, 2024 · Dyne Therapeutics Trading Down 6.0 %. DYN stock opened at $8.82 on Tuesday. The firm has a 50 day moving average of $12.59 and a 200-day moving average of $12.09. The firm has a market ... flowercampings.comWebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis. greek origin of monarchyWebDYN Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Dyne Therapeutics in the last 3 months. The average price target is $28.50 with a high forecast of $34.00 and a low forecast of $20.00. The average price target represents a 155.61% change from the last price of $11.15. flower camping saint amandWebThe Investor Relations website contains information about Dyne Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. flower camping les paludiers ★★★★WebMar 20, 2024 · positioned for growth. Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people … flower camping millauWebGet the latest Dyne Therapeutics, Inc. (DYN) stock news and headlines to help you in your trading and investing decisions. ... Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ: DYN) from ... flower campings corseWebMar 29, 2024 · Here's Why Dyne Therapeutics, Inc. (DYN) Is a Great 'Buy the Bottom' Stock Now. Dyne Therapeutics, Inc. (DYN) appears to have found support after losing … flower camping provence vallée